Current Topics in iPSCs Technology

<p>1. Regulatory and Policy Considerations in iPSC Research<br>2. HiPSCs for Population Genetics<br>3. Using Human Induced Pluripotent Stem Cells to Advance Personalized/Precision Medicine<br>4. hiPSC disease modeling with 3D organoids: Bioengineering perspective<br>5. The Differentiation of Embryonic Stem Cells and Induced Pluripotent Stem Cells into Airway and Alveolar Epithelial Cells<br>6. Transplantation of iPSC-derived human kidney organoids<br>7. An update on clinical applications of iPSCs from a genomic point of view<br>8. DNA Damage and Replication in Induced Pluripotent Stem Cells <br>9. Epigenetic modifications in induced pluripotent stem cells to boost myogenic commitment <br>10. Applications for Induced Pluripotent Stem Cells (iPSC) in Reproductive Medicine<br>11. iPSCs in Insulin Resistance, Type 2 Diabetes and the Metabolic Syndrome<br>12. Induced pluripotent stem cells for cystic fibrosis<br>13. Exploring 15q13.3 Copy Number Variants in iPSCs <br>14. Human induced pluripotent stem cells for modeling Brugada syndrome<br>15. iPSCs for Erythromycin Arrhythmogenicity Testing<br>16. Therapeutic Potential of Induced Pluripotent Stem Cell derived Extracellular Vesicles: Quo Vadis? Terra Incognito<br>17. Proteomic Approach for Creation of the Protein Marker Panels to Control for Quality of Human Induced Pluripotent Stem Cells (hiPSCs)<br>18. Application of induced pluripotent stem cells in tissue engineering <br>19. Application of iPSC-derived secretome in regenerative medicine <br>20. iPSCs and toxicology: predictive tool for present and future <br>21. Rejuvenation through iPSCs and reprogramming in vivo and in vitro</p>